# FDA Inspection 1260213 - Biogenesis, Inc - February 27, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/a36a341e-ba5d-4181-ba30-4c5bdc6f36e0
Source feed: FDA_Inspections

> FDA Inspection 1260213 for Biogenesis, Inc on February 27, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260213
- Company Name: Biogenesis, Inc
- Inspection Date: 2025-02-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1116511 - 2020-01-17](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/2c0d6a9b-d61d-4cdb-95f0-7cd9432f9b5c)
- [FDA Inspection 904579 - 2014-11-18](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/4ea78634-c3a1-4665-b55b-06382f2dd5ef)
- [FDA Inspection 765724 - 2012-02-02](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/c82679bc-9830-46f6-b746-73a00a24f859)
- [FDA Inspection 669967 - 2010-08-05](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/5dfadb4b-8746-45e0-90a5-615f3e532aba)

Company: https://www.globalkeysolutions.net/companies/biogenesis-inc/847a28b3-ca74-493b-a09f-eedbdfa0c5fc

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248